AbbVie Stock Crumbles On Mixed Earnings, Slashes 2022 Earnings Outlook
[ad_1]
AbbVie stock crumbled early Friday after the biopharma giant cut its earnings outlook and came up short on sales for its first quarter.
X
The company reported adjusted profit of $3.16 per share on $13.54 billion in sales. On average, analysts polled by FactSet expected AbbVie (ABBV) to earn $3.14 a share on $13.66 billion in sales.
In the year-earlier period, AbbVie earnings were $2.89 per share on $13.01 billion in sales.
For the year, AbbVie cut its earnings outlook to $13.92-$14.12 per share, which includes an 8-cent hit due to research and development, as well as a milestone payment from the first quarter. AbbVie stock analysts had predicted adjusted profit of $14.16 a share on $60.23 billion in sales.
In premarket trading on today’s stock market, AbbVie stock toppled 4.4% near 149.50.
More to follow.
Follow Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Eli Lilly Extends Its Breakout On First-Quarter Beat, Bullish News In Obesity
Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again
IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today
Options Trading: How To Start Using Options, How To Manage Risk
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
[ad_2]
Source link